A double blind, randomized, placebo-controlled pilot trial of individualized homeopathic medicines in heavy menstrual bleeding

Read full text Summarise with VIRAT
Authors: Khushbu Pandey, Suhisna Das, Usashi Nag, Mukta Jain, Amit Gunin, Sangita Saha, Priyanka Sen, Subhranil Saha
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

This double-blind, randomized, placebo-controlled pilot trial evaluated the efficacy of individualized homeopathic medicines (IHMs) in women with heavy menstrual bleeding (HMB). While IHMs did not demonstrate a statistically significant reduction in menstrual blood loss (PBAC) in the primary analysis, consistent trends toward improvement were observed, particularly in per-protocol and sensitivity analyses. Notably, IHMs produced a significant and robust improvement in quality of life (MMAS) compared to placebo. The intervention was safe, with no reported adverse events. These findings suggest that individualized homeopathy may serve as a beneficial, non-invasive adjunct in HMB management, particularly in enhancing patient-centered outcomes, though larger trials with objective measures are needed to confirm efficacy.

Fields of Study & Subjects

Complementary and Alternative Medicine Studies Menstrual Health and Disorders Acupuncture Treatment Research Studies

Publication details

Journal / source
Mendeley Data
Publication date
25 March 2026
Language
EN
Document type
Dataset